NEUROGESX

neurogesx-logo

NeurogesX, Inc., a biopharmaceutical company, engages in the development and commercialization of novel pain management therapies. It primarily focuses on chronic peripheral neuropathic pain, including postherpetic neuralgia (PHN), painful HIV-distal sensory polyneuropathy (HIV-DSP), and painful diabetic neuropathy (PDN). The company's lead product candidate NGX-4010 is a dermal patch containing capsaicin, a selective TRPV1 agonist designed to manage pain associated with peripheral neuropathic p... ain conditions. It is also developing NGX-1998, a non-patch liquid formulation of synthetic capsaicin, and an opioid analgesic for use in managing pain associated with other chronic pain conditions, such as cancer pain. The company was founded in 1998 as Advanced Analgesics, Inc. and changed its name to NeurogesX, Inc. in 2000. NeurogesX is headquartered in San Mateo, California.

#People #Financial #Website #More

NEUROGESX

Social Links:

Industry:
Biotechnology Medical Medical Device Neuroscience

Founded:
1998-01-01

Address:
San Carlos, California, United States

Country:
United States

Website Url:
http://www.neurogesx.com

Total Employee:
11+

Status:
Active

Contact:
16503198757

Email Addresses:
[email protected]

Total Funding:
135.44 M USD

Technology used in webpage:
Confluence Networks Data Foundry



Current Advisors List

jean-jacques-bienaime_image

Jean-Jacques Bienaime Board of Directors @ NeurogesX
Board_member

robert-nelsen_image

Robert Nelsen Member of the Board of Directors @ NeurogesX
Board_member

Current Employees Featured

jeffrey-tobias_image

Jeffrey Tobias
Jeffrey Tobias Chief Medical Office @ NeurogesX
Chief Medical Office
2005-01-01

bradford-goodwin_image

Bradford Goodwin
Bradford Goodwin Director @ NeurogesX
Director

Founder


brett-robertson_image

Brett Robertson

wendye-robbins_image

Wendye Robbins

Stock Details


Company's stock symbol is NASDAQ:NGSX

Investors List

sv-life-sciences_image

SV Health Investors

SV Health Investors investment in Post-IPO Equity - NeurogesX

alta-partners_image

Alta Partners

Alta Partners investment in Series D - NeurogesX

arch-venture-partners_image

ARCH Venture Partners

ARCH Venture Partners investment in Series D - NeurogesX

mitsubishi-corporation-life-sciences-venture_image

Mitsubishi International Corporation (MIC)

Mitsubishi International Corporation (MIC) investment in Series D - NeurogesX

global-life-science-ventures_image

Global Life Science Ventures

Global Life Science Ventures investment in Series D - NeurogesX

walden-international_image

Walden International

Walden International investment in Series D - NeurogesX

montreaux-equity-partners_image

Montreux Equity Partners

Montreux Equity Partners investment in Series D - NeurogesX

university-of-north-carolina_image

University of North Carolina at Chapel Hill

University of North Carolina at Chapel Hill investment in Series C - NeurogesX

diamond-capital-management_image

Diamond Capital Management

Diamond Capital Management investment in Series C - NeurogesX

arch-venture-partners_image

ARCH Venture Partners

ARCH Venture Partners investment in Series C - NeurogesX

Official Site Inspections

http://www.neurogesx.com Semrush global rank: 5.76 M Semrush visits lastest month: 536

  • Host name: acf3b736b777428f5.awsglobalaccelerator.com
  • IP address: 15.197.240.20
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "NeurogesX" on Search Engine